FDA rescinds marketing ban on Juul vaping products

The US Food and Drug Administration (FDA) has lifted marketing denial orders for vaping products from Juul Labs Inc. However, the FDA has not yet determined if these products will remain on the market. Juul stated that its products will continue to be available during the scientific review process. The FDA cited recent court decisions that have influenced its approach to product review. In 2022, the FDA banned the marketing of Juul products, but this ban was later stayed due to additional scientific review. Juul appealed the decision, allowing its products to remain on store shelves. The FDA clarified that the lifting of the marketing ban does not indicate whether the products will ultimately be authorized or denied. The FDA has only authorized 23 e-cigarette products after rigorous scientific review, and all e-cigarette products must have FDA authorization to be legally marketed. The American Lung Association expressed concern over the FDA’s decision, urging the FDA to issue marketing denial orders for all Juul products. The Campaign for Tobacco-Free Kids also criticized the FDA for delaying the review of Juul’s marketing applications and called for a swift denial of these applications due to Juul’s role in the youth e-cigarette epidemic. Despite these controversies, Juul remains popular among e-cigarette users, particularly young people.